{"url_path":"/sec/zntl/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1725160/0001725160-26-000045-index.html","accession_number":"0001725160-26-000045","cik":"0001725160","ticker":"ZNTL","issuer_name":"Zentalis Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1725160/0001725160-26-000045-index.html","primary_entity_key":"0001725160","primary_entity_name":"Zentalis Pharmaceuticals, Inc."},"word_count":96,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nThe following Exhibit 99.1 relating to Item 7.01 shall be deemed to be furnished, and not filed:\n\nExhibit No.\n Description\n\n99.1 \n[Press Release issued on May 21, 2026](asco2026datapressreleasefi.htm)\n\n104Cover Page Interactive Data File (embedded within the inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n ZENTALIS PHARMACEUTICALS, INC.\n\nDate: May 21, 2026 By: /s/ Julie Eastland\n\n  Julie Eastland\n\n  President and Chief Executive Officer"}